First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-11 16:36:34 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/bph.70317
文献链接: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70317
其他信息:
出版社: Wiley
作者: Yue Cheng; Xiaohong Zhu; Ye Wang; Qingqing Li; Qiao Yan; Feiyan Zeng; Shuang Li; Siyu Li; Man Chen; Ping Feng

